- Home
- EEA vs OKYO Comparison
EEA vs OKYO Comparison
Compare EEA & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EEA | OKYO |
|---|---|---|
| Founded | 1986 | 2007 |
| Country | Germany | United Kingdom |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 79.7M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | EEA | OKYO |
|---|---|---|
| Price | $11.02 | $2.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 9.2K | ★ 150.3K |
| Earning Date | 01-01-0001 | 07-18-2025 |
| Dividend Yield | ★ 1.92% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.45 | $0.90 |
| 52 Week High | $9.26 | $3.35 |
Technical Indicators
Market Signals| Indicator | EEA | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 60.27 | 49.45 |
| Support Level | $10.70 | $2.01 |
| Resistance Level | $11.33 | $2.17 |
| Average True Range (ATR) | 0.23 | 0.16 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 55.43 | 43.08 |
Price Performance
Historical ComparisonAbout EEA The European Equity Fund Inc.
European Equity Fund, Inc / MD is a United States-based diversified, closed-end management investment company. The fund seeks long-term capital appreciation through investment in equity and equity securities of issuers domiciled in Europe. Its portfolio of investments consists of different sectors such as industrials, financials, healthcare, consumer discretionary, materials, consumer staples, information technology, and other sectors.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.